4//SEC Filing
APRICUS BIOSCIENCES, INC. 4
Accession 0001017491-16-000179
CIK 0001017491operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 6:18 PM ET
Size
5.2 KB
Accession
0001017491-16-000179
Insider Transaction Report
Form 4
Morton Neil
SVP, Chief Business Officer
Transactions
- Award
Common Stock
2016-05-20+100,000→ 129,496 total
Footnotes (2)
- [F1]Award of 100,000 Restricted Stock Units ("RSUs") under the Issuer's 2012 Stock Long Term Incentive Plan with half of the underlying shares vesting on the Company's receipt of marketing approval of Vitaros in the United States by the Food and Drug Administration on or before December 31, 2018 and the other half of the underlying shares vesting on January 1, 2018, subject to the Reporting Person's continued employment or service to the Issuer through such date.
- [F2]Not applicable.
Documents
Issuer
APRICUS BIOSCIENCES, INC.
CIK 0001017491
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001017491
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 6:18 PM ET
- Size
- 5.2 KB